Below are the top 5 small-cap biotechnology stocks on the NASDAQ and the NYSE in terms of ROE.
Obagi Medical Products Inc (NASDAQ: OMPI) has a trailing-twelve-month ROE of 18.57%. OMPI’s quarterly earnings grew by 197.50% year-over-year.
Medicis Pharmaceutical Corp (NYSE: MRX) has a trailing-twelve-month ROE of 16.66%. MRX’s quarterly earnings growth stands at 10,651.10% year-over-year.
American Oriental Bioengineering Inc (NYSE: AOB) has a trailing-twelve-month ROE of 9.94%. AOB lost 38.90% during the past 52 weeks, while the S&P 500 rose 17.88% over the same period.
Emergent BioSolutions Inc (NYSE: EBS) has a trailing-twelve-month ROE of 9.82%. EBS has a 52 week trading range of $11.67-$19.95.
3SBio Inc (NASDAQ: SSRX) has a trailing-twelve-month ROE of 9.51%. SSRX has a quarterly earnings growth of 67.80% year-over-year.
Read more from Benzinga’s Company news.
Similar Posts:
- Benzinga’s After Hours Decliners (MGM, LTC)
- Dramatic Rally Sweeps Across Wall Street (SPY, QQQQ, GLD, USO, TLT, UUP)
- PALM Soars Again In Pre-Market Trading As Rumors Abound
- Benzinga’s Top ETF Decliners (SQQQ, TYP, FAS, SGG )
- Host Hotels & Resorts Swings To Profit (HST)
